Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dillon

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Multiple Sclerosis and Related Disorders|January 22, 2021
COVID-19 in ocrelizumab-treated people with multiple sclerosisRichard Hughes, Louise Whitley, Kocho Fitovski, et al.
BMC Pregnancy and Childbirth|April 18, 2015
Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot studyPaul Dillon, Kirsty K O'Brien, Ronan McDonnell, et al.
Gastroenterology|June 4, 2013
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver diseaseSunder Mudaliar, Robert R Henry, Arun J Sanyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular CarcinomaAndrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Multiple Sclerosis and Related Disorders|January 22, 2021
COVID-19 in ocrelizumab-treated people with multiple sclerosisRichard Hughes, Louise Whitley, Kocho Fitovski, et al.
BMC Pregnancy and Childbirth|April 18, 2015
Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot studyPaul Dillon, Kirsty K O'Brien, Ronan McDonnell, et al.
Gastroenterology|June 4, 2013
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver diseaseSunder Mudaliar, Robert R Henry, Arun J Sanyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular CarcinomaAndrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Pageof 5